Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia

Biological Psychiatry

Volumn 42, Issue 2, 1997, Pages 151-154

  Akiyoshi, Jotaro ^a   Isogawa, Koichi ^a   Tsutsumi, Takashi ^a   Kasturagi, Satomi ^a   Kohno, Keiko ^a   Furuta, Mariko ^a   Yamamoto, Yukiko ^a   Yamada, Kumiko ^a   Fujii, Isao ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Calcium; Cholecystokinin; Intracellular calcium mobilization; Panic disorder; T cell

Indexed keywords

CALCIUM; CHOLECYSTOKININ; TETRAGASTRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; PANIC; PRIORITY JOURNAL; SCHIZOPHRENIA; T LYMPHOCYTE;

ADULT; AROUSAL; BLOOD-BRAIN BARRIER; CALCIUM; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PANIC DISORDER; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; SCHIZOPHRENIA; T-LYMPHOCYTES; TETRAGASTRIN;

EID: 0030952154     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00249-7     Document Type: Article

References (27)

1. 2C receptors. J Neurochem 64:2473-2479.
2. Akiyoshi J, Moriyama T, Isogawa K, Miyamoto M, Sasaki I, Kuga K, et al (1996): CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder. J Neurochem 66:1610-1616.
3. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. rev. Washington, DC: American Psychiatric Press.
4. Aune TM, Kelley KA, Ranges GE, Bombara MP (1990): Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J Immunol 145:1826-1831.
5. Bouthillier A, de Montigny C (1988): Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: An electrophysiological study in the rat. Eur J Pharmacol 151:135-138.
6. Bradwejn J, de Montigny C (1984): Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurons. Nature 313:363-364.
7. Bradwejn J, Koszycki D, Meterissian G (1990): Cholecystokinin tetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry 35:83-85.
8. Bradwejn J, Koszycki D, Shriqui C (1991): Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Arch Gen Psychiatry 48:603-610.
9. Bradwejn J, Koszycki D, Payeur R, Bourin M, Borthwick H (1992): Replication of action of cholecystokinin tetrapeptide in panic disorder: Clinical and behavioral findings. Am J Psychiatry 149:962-964.
10. Bradwejn J, Koszycki D, Couetoux du Tertre A, van Megen H, den Boer J, Westenberg H, et al (1994a): The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecytokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry 51:486-493.
11. Bradwejn J, Koszycki D, Couetoux du Tertre A, Paradis M, Bourin M (1994b): Effect of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers. Psychopharmacology 114:257-261.
12. Bradwejn J, Koszycki D, Paradis M, Reece P, Sedman R (1996): The effects of CI-988 on CCK-4-induced panic in healthy volunteers. Biol Psychiatry 38:742-746.
13. Brambilla F, Bellodi L, Perna G, Garberi A, Panerai A, Sacerdote P (1994): T cell cholecystokinin concentrations in panic disorder. Am J Psychiatry 150:1111-1113.
14. Brodde O-E, Kretsch R, Ikezono K, Zerkowski H-R, Reidemeister JC (1986): Human beta-adrenoceptors: Relation of myocardial and T cell beta-adrenoceptor density. Science 231: 1584-1585.
15. Brodin K, Ogren S-V, Brodin E (1994): Clomipramine and clonazepam increase cholecystokinin levels in rat ventral tegmental area and limbic regions. Eur J Pharmacol 263: 175-180.
16. Csonka E, Fekete M, Nagy GY, Szanto-Fekete M, Telegdy G, Penke B, et al (1988): Anxiogenic effect of cholecystokinin in rats. Peptides 249-252.
17. Dampney RAL, Goodchild AK, Robertson LG, Montgomery W (1982): Role of ventrolateral medulla in vasornotor regulation: A correlative anatomical and physiological study. Brain Res 249:223-235.
18. de Montigny C (1989): Cholecystokinin tetrapeptide induces panic like attacks in healthy volunteers. Arch Gen Psychiatry 46:511-517.
19. Gordon M, Cohen JJ, Wilson BI (1978): Muscarinic cholinergic receptors in murine T cells: Demonstration by direct binding. Proc Natl Acad Sci USA 75:2902-2904.
20. Harro J, Lang A, Vasar E (1990): Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain. Eur J Pharmacol 180:77-83.
21. Harro J, Marcusson J, Oreland L (1992): Alterations in brain cholecystokinin receptors in suicide victims. Eur Neuropsychopharmacol 2:57-63.
22. Jordan D, Spyer KM (1986): Brainstem integration of cardiovascular and pulmonary afferent activity. Prog Brain Res 67: 295-314.
23. B antagonist, in panic disorder. Biol Psychiatry 37:462-466.
24. 2+ concentration in the human JURKAT T lymphocyte cell line. Eur J Pharmacol 245:241-246.
25. Lin CW, Holiday MW, Barrett RW, Wolfram CAW, Miller TR, Witte D, et al (1989): Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: Studies with C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Mol Pharmacol 36:881-886.
26. Lydiard RB, Ballenger JC, Laraia MT, Fossey MD, Beinfeld MC (1992): CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. Am J Psychiatry 149:691-693.
27. Strom BT, Lane AM, George K (1981): The parallel, time-dependent, bimodal change in T cell cholinergic binding activity and cholinergic influence upon T cell-mediated cytotoxicity after T cell activation. J Immunol 127:705-710.